# Malaria Diagnosis Treatment Market

> Africa Malaria Diagnosis & Treatment Market Research Report Information, by Diagnosis (Rapid Diagnostic Tests (RDT’s), Molecular diagnostics, Microscopy), by Malarial Parasite (Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae and Plasmodium Ovale) - Forecast till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.35%
- **2024:** $ 763.93 Million
- **2025:** $ 813.56 Million
- **2035:** $ 1,361.23 Million
- **Key Players:** Roche (CH), Abbott (US), Siemens Healthineers (DE), BD (US), Thermo Fisher Scientific (US), Cepheid (US), Daiichi Sankyo (JP), Novartis (CH), GSK (GB)

**Report ID:** MRFR/MED/2166-HCR · **Pages:** 60 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/malaria-diagnosis-treatment-market-2952

---

## Market Summary

## **Africa Malaria Diagnosis & Treatment Market Overview**

The Africa malaria diagnosis & treatment market is projected to reach USD 2.81 Billion by 2032 at 6.9% CAGR during the forecast period 2023-2032.

Malaria is an infectious disease caused by parasitic protozoa of the Plasmodium type. The symptoms include fever, fatigue, vomiting, and severe headaches and may lead to seizures, coma, or even death if untreated. Malaria is primarily a disease of the tropical and subtropical regions. The carrier of malaria is the female anopheles mosquito and hence there is a seasonal variation in the cases of malaria. Most cases of malaria are caused by P. falciparum because other types of plasmodium such as P. vivax, P. ovale, and P. malariae generally cause a milder form of malaria.

According to World Health Organization (WHO), the global incidence of malaria between 2010 and 2015, fell by 21% and the malaria mortality fell by 29%. However the African region carries a disproportionately high share of the global malaria burden and accounted for 90% of malaria cases and 92% of malaria deaths worldwide and sub-Saharan Africa accounted for 76% of malaria cases and 75% deaths globally.

Thus, unmet medical needs is the single most important driver of malaria. Other important market drivers are the hot and humid climatic conditions of certain parts of Africa, presence of population groups at higher risk of contracting malaria such as infants, children under 5 years of age, patients with low immunity such as those with HIV/AIDS, mobile populations and travelers.

The growth of government programs against malaria and the support given by international bodies such as WHO is also a market driver. The market barriers include high cost of imported malaria diagnostic kits, low penetration of healthcare in Africa, low per capita income, low number of healthcare professionals in Africa etc. The political causes include massive corruption, low political power of citizens especially in nondemocratic nations, civil war in regions such as Malawi etc.

**Study Objectives for Africa Malaria Diagnosis & Treatment Market:**

**Africa Malaria Diagnosis & Treatment Market Share by Malarial Parasite, 2016 (%):**

**Intended Audience**

**Key Players for Africa Malaria Diagnosis & Treatment Market:**

Some of the key players in Africa Malaria Diagnosis & Treatment Market are: Alere Inc., Access Bio Inc., Premier Medical Corporation, Beckman Coulter/Danaher, bioMerieux, [Novartis Diagnostics](https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-announce-decision-move-phase-3-study-novel-ganaplacidelumefantrine-sdf-combination-adults-and-children-malaria), Siemens Healthcare, Bio-Rad Laboratories, Cipla Inc., Ipca Laboratories Ltd., Uni-Med India, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Sanofi among others.

## **Africa Malaria Diagnosis & Treatment Market Segment Insights**

Africa Malaria Diagnosis & Treatment Market has been segmented on the basis of technique which comprises rapid diagnostic tests (RDT’S), [molecular diagnostics](../../../reports/molecular-diagnostics-market-1171) and microscopy. On the basis of malarial parasite; market is segmented into plasmodium falciparum, plasmodium vivax, plasmodium malariae and plasmodium ovale.

### **Regional Analysis of Africa Malaria Diagnosis & Treatment Market:**

The healthcare sector of Africa is divided between private and state. The public healthcare expenditure accounts for approximately 48 % of total health expenditure in 2014 with variation in different countries. Local manufacturing represents a poor outlook which is limited to consumables and ordinary articles and there are a handful of high tech devices manufacturers. 

Africa is extremely dependent on imports for medical devices and imports account for approximately 90 % of total market for medical devices and Chinese medical device suppliers dominate the scenario. Among the regions of Africa, South Africa and Egypt account for 40 % of market. 

Other important nations are Nigeria, Morocco and Algeria. Collaboration with large global companies and technical transfer will remain the key strategy for developing the regional African market as can be seen by the example of China. The report of Africa Malaria Diagnosis & Treatment Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. 

The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

## Market Drivers

### Rising Awareness and Education

Rising awareness and education regarding malaria prevention and treatment are crucial drivers of the Global Africa Malaria Diagnosis and Treatment Market Industry. Public health campaigns and educational programs are increasingly emphasizing the importance of early diagnosis and effective treatment. This heightened awareness leads to increased demand for diagnostic services and antimalarial medications. Organizations such as the World Health Organization are actively promoting education on malaria, which is likely to result in more individuals seeking timely medical intervention. As awareness grows, the market is expected to expand, with projections indicating a market value of 3.43 USD Billion by 2035, highlighting the long-term potential of this sector.

### Increasing Prevalence of Malaria

The Global Africa Malaria Diagnosis and Treatment Market Industry is significantly influenced by the rising incidence of malaria across various regions in Africa. In 2024, the market is valued at approximately 0.98 USD Billion, reflecting the urgent need for effective diagnostic tools and treatment options. Countries like Nigeria and the Democratic Republic of the Congo report high malaria cases, necessitating enhanced healthcare interventions. This growing prevalence drives investments in innovative diagnostic technologies and treatment methodologies, aiming to reduce the disease burden. As awareness increases, the demand for rapid diagnostic tests and [antimalarial drugs](https://www.marketresearchfuture.com/reports/antimalarial-drugs-market-22076) is expected to surge, further propelling market growth.

### Government Initiatives and Funding

Government initiatives play a pivotal role in shaping the Global Africa Malaria Diagnosis and Treatment Market Industry. Various African governments, alongside international organizations, are committing substantial resources to combat malaria. For instance, funding for malaria control programs has seen a notable increase, with initiatives aimed at improving diagnostic capabilities and treatment accessibility. These efforts are crucial in regions where malaria remains endemic. The financial backing from governments is likely to enhance the availability of rapid diagnostic tests and effective treatments, thereby fostering a more robust healthcare infrastructure. This collaborative approach is expected to significantly impact market dynamics in the coming years.

### Emerging Partnerships and Collaborations

Emerging partnerships and collaborations among stakeholders are shaping the Global Africa Malaria Diagnosis and Treatment Market Industry. Collaborative efforts between governments, non-governmental organizations, and private sector entities are fostering innovation and resource sharing. These partnerships aim to enhance research and development of new diagnostic tools and treatment options, addressing the unique challenges posed by malaria in Africa. By pooling resources and expertise, stakeholders can accelerate the development and distribution of effective solutions. This collaborative approach is likely to enhance the overall effectiveness of malaria control strategies, contributing to a more sustainable market environment.

### Technological Advancements in Diagnostics

Technological advancements are transforming the Global Africa Malaria Diagnosis and Treatment Market Industry, particularly in the realm of diagnostics. Innovations such as molecular diagnostics and rapid diagnostic tests are becoming increasingly prevalent, enabling quicker and more accurate malaria detection. These technologies not only improve patient outcomes but also facilitate timely treatment, which is essential in managing malaria effectively. The integration of mobile health technologies further enhances access to diagnostic services in remote areas. As the market evolves, it is anticipated that these advancements will contribute to a compound annual growth rate of 12.1% from 2025 to 2035, reflecting the growing reliance on technology in healthcare.

## Future Outlook

The Malaria Diagnosis Treatment Market is projected to grow at a 5.35% CAGR from 2025 to 2035, driven by technological advancements, increased funding, and rising awareness.

**New opportunities:**

- Development of mobile diagnostic units for remote areas.
- Integration of AI-driven analytics in treatment protocols.
- Expansion of telemedicine services for malaria management.

By 2035, the market is expected to achieve substantial growth, enhancing global malaria treatment accessibility.

## Segment Insights

### By Diagnosis Method: Rapid Diagnostic Test (Largest) vs. Microscopy (Fastest-Growing)

In the Malaria Diagnosis Treatment Market, the Rapid Diagnostic Test (RDT) holds the largest share among the diagnosis methods, facilitated by its ease of use and quick results. RDTs enable healthcare providers to deliver timely diagnoses, particularly in regions with limited resources, thereby enhancing malaria control efforts. Microscopy has traditionally been a core method in malaria diagnosis but occupies a smaller share. It requires skilled personnel and laboratory settings, limiting its accessibility in remote areas, although it remains a gold standard for accuracy.
The market is witnessing a growing trend towards rapid diagnostic methods, as they are critical in the fight against malaria. This shift is driven by an increased awareness of early detection and treatment, coupled with advancements in diagnostic technologies. The growing incidence of malaria in endemic areas is pushing healthcare systems to adopt faster and more reliable diagnostic tools, with RDTs leading the way. Microscopy, while still relevant, is evolving to incorporate new techniques that increase efficiency and accuracy, thereby contributing to its projected growth in the coming years.

Diagnosis Methods: RDT (Dominant) vs. PCR (Emerging)

The Rapid Diagnostic Test (RDT) is at the forefront of malaria diagnosis, characterized by its rapid and user-friendly nature. It enables healthcare workers, even in low-resource settings, to deliver timely diagnoses and treatment options, thereby playing a crucial role in reducing disease burden. In contrast, the Polymerase Chain Reaction (PCR) method, though emerging, offers high sensitivity and specificity in detecting malaria pathogens. PCR is gaining traction, particularly for research and in confirming cases where traditional methods fail. The advancement of PCR technology provides opportunities to enhance its accessibility, making it a promising contender in the malaria diagnosis landscape as it becomes more integrated into routine screening and advanced diagnostic settings.

### By Treatment Type: Antimalarial Drugs (Largest) vs. Combination Therapy (Fastest-Growing)

In the Malaria Diagnosis Treatment Market, Antimalarial Drugs constitute the largest segment, reflecting their widespread use and acceptance in malaria treatment protocols. This segment dominates due to the extensive range of drugs available, including artemisinin-based therapies, which have proven effective against malaria parasites. Combination Therapy is also gaining in prominence, rapidly increasing its market share as healthcare providers recognize its ability to improve treatment outcomes and minimize drug resistance, positioning it as a crucial strategy for effective malaria management.

Combination Therapy (Dominant) vs. Supportive Care (Emerging)

Combination Therapy stands out as a dominant treatment approach in the Malaria Diagnosis Treatment Market due to its dual-action mechanism, which not only enhances efficacy but also reduces the likelihood of resistance development among malaria parasites. This treatment modality is often a blend of different antimalarial drugs, maximizing therapeutic outcomes. On the other hand, Supportive Care is emerging as a vital component of malaria management, focusing on symptom alleviation and patient recovery. Though it currently holds a smaller market share, increasing recognition of the importance of comprehensive patient care is driving growth in this segment, making it an essential consideration in future malaria treatment strategies.

### By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

In the Malaria Diagnosis Treatment Market, hospitals represent the largest segment, accounting for a significant portion of the overall demand. They play a crucial role in providing in-depth testing and treatment for malaria, benefiting from advanced diagnostic technologies and a high patient influx. On the other hand, clinics are becoming increasingly important as more individuals seek out convenient healthcare options for malaria diagnosis and treatment. Their growing presence is reshaping how care is accessed, especially in rural or underserved areas. In addition to hospitals and clinics, home care and diagnostic laboratories also make up essential segments but with comparatively different market dynamics.

Hospitals (Dominant) vs. Clinics (Emerging)

Hospitals continue to dominate the Malaria Diagnosis Treatment Market due to their comprehensive capabilities in managing severe cases and advanced laboratory services. They often invest in cutting-edge diagnostic tools and maintain a broad array of treatment options. However, clinics are on the rise, particularly in urban settings, where they offer accessible and often quicker malaria diagnostic services. These facilities capitalize on increasing health awareness and are becoming popular for routine check-ups, significantly easing the burden on hospitals. The emergence of clinics is also driven by the need for lower-cost alternatives and faster services, appealing to patients who prioritize convenience.

## Regional Market Share Analysis

### North America : Established Healthcare Market

The North American malaria diagnosis treatment market is projected to grow steadily, driven by advanced healthcare infrastructure and increasing awareness of malaria prevention. With a market size of $50.0M, the region benefits from strong regulatory support and funding for research initiatives. The demand for rapid diagnostic tests and innovative treatment options is on the rise, fueled by ongoing public health campaigns and collaborations between government and private sectors.

Leading countries like the US and Canada are at the forefront of this market, with key players such as Abbott and Thermo Fisher Scientific actively contributing to advancements in malaria diagnostics. The competitive landscape is characterized by a focus on technological innovation and strategic partnerships. As the region continues to invest in healthcare solutions, the presence of established companies ensures a robust market environment.

### Europe : Innovative Research Hub

Europe's malaria diagnosis treatment market, valued at $100.0M, is characterized by a strong emphasis on research and innovation. The region benefits from stringent regulatory frameworks that promote the development of effective diagnostic tools and treatments. Increased funding from governmental and non-governmental organizations has catalyzed advancements in malaria research, leading to improved healthcare outcomes and heightened awareness of malaria's impact.

Countries like Germany, France, and the UK are leading the charge in malaria diagnostics, with key players such as Siemens Healthineers and GSK making significant contributions. The competitive landscape is marked by collaborations between public health agencies and private companies, fostering an environment conducive to innovation. As Europe continues to prioritize malaria control, the market is expected to expand further, supported by ongoing research initiatives.

### Asia-Pacific : Emerging Powerhouse

The Asia-Pacific region holds the largest market share in the malaria diagnosis treatment sector, valued at $550.0M. This growth is driven by rising malaria incidence rates, increased healthcare investments, and government initiatives aimed at eradicating the disease. The demand for effective diagnostic tools and treatments is surging, supported by collaborations between governments and international organizations to enhance healthcare access and quality.

Leading countries such as India, China, and Australia are pivotal in this market, with key players like Roche and Daiichi Sankyo actively involved in developing innovative solutions. The competitive landscape is dynamic, with a focus on local partnerships and tailored healthcare strategies. As the region continues to address malaria challenges, the market is poised for significant growth, driven by both public and private sector efforts.

### Middle East and Africa : Resource-Rich Frontier

The Middle East and Africa region, with a market size of $63.93M, is witnessing a growing demand for malaria diagnosis treatments. This growth is fueled by increasing malaria prevalence, particularly in sub-Saharan Africa, and heightened awareness of the disease's impact on public health. Government initiatives and international aid are pivotal in enhancing healthcare infrastructure and access to diagnostic tools, driving market expansion.

Countries like South Africa and Nigeria are leading the way in malaria diagnostics, with key players such as BD and Cepheid playing crucial roles in providing innovative solutions. The competitive landscape is characterized by a mix of local and international companies, focusing on affordable and accessible healthcare solutions. As the region continues to combat malaria, the market is expected to grow, supported by collaborative efforts between governments and health organizations.

## Competitive Benchmarking

The Malaria Diagnosis Treatment Market is characterized by a dynamic competitive landscape, driven by the urgent need for effective diagnostic solutions and treatments. Key players such as Roche (CH), Abbott (US), and Siemens Healthineers (DE) are at the forefront, each adopting distinct strategies to enhance their market presence. Roche (CH) focuses on innovation, particularly in developing rapid diagnostic tests that can be deployed in remote areas, thereby addressing accessibility issues. Abbott (US) emphasizes partnerships with local health organizations to improve distribution channels, while Siemens Healthineers (DE) is investing in digital transformation to streamline diagnostic processes and enhance data analytics capabilities. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological advancement and accessibility.In terms of business tactics, companies are localizing manufacturing to reduce costs and improve supply chain efficiency. The market appears moderately fragmented, with several players vying for market share, yet the influence of major companies is substantial. This competitive structure allows for a diverse range of products and services, catering to various regional needs and preferences.

In November  Roche (CH) announced the launch of a new point-of-care diagnostic test that significantly reduces the time required for malaria detection. This innovation is expected to enhance patient outcomes by facilitating quicker treatment decisions, particularly in endemic regions. The strategic importance of this move lies in Roche's commitment to addressing the critical need for timely diagnosis, which is essential for effective malaria management.

In October  Abbott (US) expanded its collaboration with the Global Fund to Fight AIDS, Tuberculosis and Malaria, aiming to enhance access to malaria diagnostics in sub-Saharan Africa. This partnership is pivotal as it aligns Abbott's resources with global health initiatives, potentially increasing the reach of its diagnostic solutions. The strategic significance of this collaboration underscores Abbott's focus on social responsibility and market penetration in underserved areas.

In September  Siemens Healthineers (DE) unveiled a new AI-driven platform designed to optimize malaria diagnostic workflows in healthcare facilities. This platform integrates advanced analytics to improve accuracy and efficiency in test results. The strategic relevance of this development highlights Siemens' commitment to leveraging technology to enhance diagnostic capabilities, which may set a new standard in the industry.

As of December  current trends in the Malaria Diagnosis Treatment Market indicate a strong shift towards digitalization, sustainability, and AI integration. Strategic alliances are increasingly shaping the competitive landscape, fostering innovation and collaboration among key players. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, reliability in supply chains, and enhanced patient care solutions. This transition suggests that companies that prioritize these aspects may gain a competitive edge in the market.

## Report Scope

| MARKET SIZE 2024 | 763.93(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 813.56(USD Million) |
| MARKET SIZE 2035 | 1361.23(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.35% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Roche (CH), Abbott (US), Siemens Healthineers (DE), BD (US), Thermo Fisher Scientific (US), Cepheid (US), Daiichi Sankyo (JP), Novartis (CH), GSK (GB) |
| Segments Covered | Diagnosis Method, Treatment Type, End User |
| Key Market Opportunities | Integration of rapid diagnostic tests with telemedicine enhances access to Malaria Diagnosis Treatment Market. |
| Key Market Dynamics | Technological advancements in diagnostics enhance treatment efficacy, driving competitive dynamics in the Malaria Diagnosis Treatment Market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Malaria Diagnosis Treatment Market?**
A: The market valuation reached 763.93 USD Million in 2024.

**Q: What is the projected market size for the Malaria Diagnosis Treatment Market by 2035?**
A: The market is expected to grow to 1361.23 USD Million by 2035.

**Q: What is the expected CAGR for the Malaria Diagnosis Treatment Market during the forecast period 2025 - 2035?**
A: The market is anticipated to experience a CAGR of 5.35% from 2025 to 2035.

**Q: Which companies are considered key players in the Malaria Diagnosis Treatment Market?**
A: Key players include Roche, Abbott, Siemens Healthineers, BD, Thermo Fisher Scientific, Cepheid, Hologic, Bio-Rad Laboratories, and Daiichi Sankyo.

**Q: What are the primary diagnosis methods used in the Malaria Diagnosis Treatment Market?**
A: The main diagnosis methods include Rapid Diagnostic Tests, Microscopy, Polymerase Chain Reaction, and Serological Tests.

**Q: How much revenue did Rapid Diagnostic Tests generate in 2024?**
A: Rapid Diagnostic Tests generated approximately 300.0 to 550.0 USD Million in 2024.

**Q: What is the revenue range for Antimalarial Drugs in the Malaria Diagnosis Treatment Market?**
A: Antimalarial Drugs generated revenue between 300.0 and 550.0 USD Million in 2024.

**Q: Which end-user segment is expected to dominate the Malaria Diagnosis Treatment Market?**
A: Hospitals are projected to be the leading end-user segment, generating 300.0 to 550.0 USD Million in 2024.

**Q: What is the revenue range for Combination Therapy in the Malaria Diagnosis Treatment Market?**
A: Combination Therapy generated revenue between 200.0 and 400.0 USD Million in 2024.

**Q: What is the expected growth trend for the Malaria Diagnosis Treatment Market by 2035?**
A: The market is likely to expand significantly, driven by advancements in diagnosis and treatment methods.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/malaria-diagnosis-treatment-market-2952*